Estrogen-related receptor agonists as exercise mimics
Physical activity is known to have many benefits for both body and mind. It strengthens the muscles, improves endurance, contributes to heart health and helps prevent many diseases. But it is not always easy or possible for everyone to engage in physical activity regularly.
The research community is looking for innovative ways to make the benefits of physical activity accessible even to those who cannot do it. One of the promising ways is the development of medicines that can mimic the effects of physical activity on the body.
New research presents a compound called SLU-PP-332 that may be a breakthrough in this field.
The compound, which was developed by a team of researchers from St. Louis University in the United States, works by activating special receptors (ERRs) involved in important physiological processes in the muscle.
Experiments conducted in mice showed that the compound SLU-PP-332 causes an increase in the type of muscle fibers resistant to fatigue, and leads to a significant improvement in endurance when running.
The researchers believe that SLU-PP-332 could benefit people who suffer from muscle atrophy, weakness or other conditions that prevent them from exercising.
Also, the compound may be effective in treating diseases such as obesity, heart failure and age-related decline in kidney function.
Developing drugs to mimic physical activity is a relatively new field of research, and there is still a long way to go before these results become available treatments for humans.
However, the current research gives new hope to many people who cannot enjoy the benefits of physical activity traditionally.
Here are some main points from the study:
- Physical activity is beneficial for both body and mind.
- Researchers are developing drugs that can mimic the effects of physical activity.
- A compound called SLU-PP-332 may improve endurance and muscle endurance.
- SLU-PP-332 may benefit people with muscle wasting, weakness, or other conditions that prevent them from exercising.
- SLU-PP-332 may be effective in treating diseases such as obesity, heart failure, and age-related decline in kidney function.
- Developing drugs to mimic physical activity is a relatively new field of research, and there is still a long way to go before these results become available treatments for humans.
.
References:
https://www.eurekalert.org/news-releases/1037097
